Sign up for the QMED & MD+DI Daily newsletter.
Temporary Use of Heart Pump Shows Positive Results
Thoratec Inc.'s (Pleasanton, CA) heart pump may be part of a cure for congestive heart failure, according to a study published in the New England Journal of Medicine and reported by the Associated Press. A British study found that using Thoratec's pump to power the heart temporarily while administering drugs to shrink its size tripled the usual recovery rate.
November 6, 2006
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "MDDI")
Late-stage congestive heart failure is normally considered a death sentence, but eight of the 24 patients in the study (which was funded by Thoratec) fully recovered. The procedure must now be confirmed in larger trials before a premarket approval application is filed.
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)
